Form 4: Incyte Corp Executive Reports Routine Share Dispositions for Tax Obligations
Insider Transaction Report
Herve Hoppenot, a Director and Special Advisor to the CEO of Incyte Corp, reported the disposition of shares to cover tax withholding obligations related to previously vested equity awards.
Summary
- Herve Hoppenot, a Director and Special Advisor to the CEO of Incyte Corp (INCY), reported two transactions involving the disposition of common stock.
- On July 14, 2025, 4,961 shares of common stock were disposed of at a price of $69.98 per share.
- On July 15, 2025, an additional 4,713 shares of common stock were disposed of at a price of $68.25 per share.
- These dispositions, totaling 9,674 shares, were shares automatically withheld by Incyte Corp to satisfy tax withholding obligations upon the settlement of Restricted Stock Units (RSUs) or earned performance shares.
- Following these transactions, Herve Hoppenot beneficially owns 517,146 shares of Incyte Corp common stock directly.
- The reported beneficial ownership includes an aggregate of 73,486 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not yet vested.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transactions represent routine share dispositions for tax withholding purposes, which is a common and expected event for executives receiving equity compensation. It does not indicate a change in investment thesis or company performance.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing is a routine insider transaction report, common across all industries, reflecting the disposition of shares by an executive to cover tax liabilities arising from equity compensation. It does not provide specific insights into broader industry trends or competitive dynamics within the biotechnology or pharmaceutical sector.
Stakeholder Impact
- Shareholders: Minimal direct impact as these are routine tax-related dispositions, not open market sales indicating a change in confidence. The executive retains a significant beneficial ownership.
- Employees: No direct impact indicated beyond the executive's compensation structure.
Key Dates
| Date | Description |
|---|---|
| 07/14/2025 | Date of disposition of 4,961 shares of common stock for tax withholding. |
| 07/15/2025 | Date of disposition of 4,713 shares of common stock for tax withholding. |
| 07/16/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Keywords
Incyte Corp, INCY, Form 4, Insider Transaction, Share Disposition, Tax Withholding, Restricted Stock Units, Performance Shares, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.